Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE
Abstract Type C hepatic encephalopathy (HE) is a neuropsychiatric disease caused by chronic liver disease. Management of type C HE remains an important challenge because treatment options are limited. Both the antibiotic rifaximin and probiotics have been reported to reduce the symptoms of HE, but l...
Guardado en:
Autores principales: | Emmanuelle Flatt, Valérie A. McLin, Olivier Braissant, Katarzyna Pierzchala, Paola Mastromarino, Stefanita-Octavian Mitrea, Dario Sessa, Rolf Gruetter, Cristina Cudalbu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7ef8e8b4f0c43e88d7e80c9cb740c5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease
por: Veronika Rackayová, et al.
Publicado: (2021) -
Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia MD, et al.
Publicado: (2011) -
Approach to Neurological Channelopathies and Neurometabolic Disorders in Newborns
por: Inn-Chi Lee
Publicado: (2021) -
Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia
por: Ana Rivera-Barahona, et al.
Publicado: (2017) -
An analysis framework for the integration of broadband NIRS and EEG to assess neurovascular and neurometabolic coupling
por: P. Pinti, et al.
Publicado: (2021)